Leading pharmaceutical firms' quarterly sales improve

Korea's major drug makers reported two-digit growth in its sales on average during the first three months of this year, citing improved business performance.

Experts attributed better business performance of pharmaceutical firms mainly to brisk sales in new drugs and first generics, cost-sensitive corporate management by curtailing significant portion of general administrative selling ...